These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35105490)

  • 21. Gastrointestinal Bleeding After HeartMate II or HVAD Implantation: Incidence, Location, Etiology, and Effect on Survival.
    Kawabori M; Kurihara C; Critsinelis AC; Sugiura T; Kaku Y; Civitello AB; Rosengart TK; Morgan JA
    ASAIO J; 2020 Mar; 66(3):283-290. PubMed ID: 30973400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal Bleeding During the Index Hospitalization for Mechanical Circulatory Support Devices Implantation, a Nationwide Perspective.
    Abbas A; Mahmoud A; Ahmed M; Aranda J; Klodell CT; Draganov PV
    Dig Dis Sci; 2017 Jan; 62(1):161-174. PubMed ID: 27510753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal bleeding and pro-angiogenic shift in the angiopoietin axis with continuous flow left ventricular assist device implantation.
    Edwards AL; Wilcox CM; Beasley M; Pamboukian SV; Mannon P; Peter S
    Am J Med Sci; 2023 Oct; 366(4):278-285. PubMed ID: 37506847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does endoscopic intervention prevent subsequent gastrointestinal bleeding in patients with left ventricular assist devices? A retrospective study.
    Palchaudhuri S; Dhawan I; Parsikia A; Birati EY; Wald J; Siddique SM; Fisher LR
    World J Gastroenterol; 2021 Jul; 27(25):3877-3887. PubMed ID: 34321851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing of Gastrointestinal Bleeding After Implantation of Left Ventricular Assist Devices Associates With Anatomic Location, Presentation, and Management.
    Tabibian JH; Rhoades DP; Forde KA; McLean RC; Chandrasekhara V
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):448-454. PubMed ID: 29906524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal Bleeding With Left Ventricular Assist Devices (LVAD): Locating the Leak and Identifying Outcomes.
    Malik S; Malik SA; Ulmer LL; Jha LK; Strupp MS; Raichlin E; Lyden ER; Hewlett AT
    J Clin Gastroenterol; 2019; 53(5):e202-e207. PubMed ID: 29688916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digoxin Is Associated With a Decreased Incidence of Angiodysplasia-Related Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Vukelic S; Vlismas PP; Patel SR; Xue X; Shitole SG; Saeed O; Sims DB; Chinnadurai T; Shin JJ; Forest SJ; Goldstein DJ; Jorde UP
    Circ Heart Fail; 2018 Aug; 11(8):e004899. PubMed ID: 30354557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Incidence, Predictors and Outcomes of Gastrointestinal Bleeding in Patients with Left Ventricular Assist Device (LVAD).
    Jabbar HR; Abbas A; Ahmed M; Klodell CT; Chang M; Dai Y; Draganov PV
    Dig Dis Sci; 2015 Dec; 60(12):3697-706. PubMed ID: 26072320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-operative pectoralis muscle area index is associated with biomarkers of inflammation and endotoxemia and predicts clinical outcomes after left ventricular assist device implantation: A cohort study.
    Carey MR; Ladanyi A; Nishikawa M; Bordon A; Leb JS; Pinsino A; Driggin E; Latif F; Sayer GT; Clerkin KJ; Takeda K; Uriel N; Colombo PC; Yuzefpolskaya M
    Artif Organs; 2024 Dec; 48(12):1494-1501. PubMed ID: 39096053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System.
    Goldstein DJ; Aaronson KD; Tatooles AJ; Silvestry SC; Jeevanandam V; Gordon R; Hathaway DR; Najarian KB; Slaughter MS;
    JACC Heart Fail; 2015 Apr; 3(4):303-13. PubMed ID: 25770405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Predictors for Repeat Hospitalizations in Left Ventricular Assist Device (LVAD) Patients With Gastrointestinal Bleeding.
    Welden CV; Truss W; McGwin G; Weber F; Peter S
    Gastroenterology Res; 2018 Apr; 11(2):100-105. PubMed ID: 29707076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left Ventricular Assist Devices Impact Hospital Resource Utilization Without Affecting Patient Mortality in Gastrointestinal Bleeding.
    Li F; Hinton A; Chen A; Mehta NK; Eldika S; Zhang C; Hussan H; Conwell DL; Krishna SG
    Dig Dis Sci; 2017 Jan; 62(1):150-160. PubMed ID: 27858326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients.
    Lopilato AC; Doligalski CT; Caldeira C
    Artif Organs; 2015 Nov; 39(11):939-44. PubMed ID: 25912789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significantly higher rates of gastrointestinal bleeding and thromboembolic events with left ventricular assist devices.
    Shrode CW; Draper KV; Huang RJ; Kennedy JL; Godsey AC; Morrison CC; Shami VM; Wang AY; Kern JA; Bergin JD; Ailawadi G; Banerjee D; Gerson LB; Sauer BG
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1461-7. PubMed ID: 24480675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal Bleeding during Continuous-Flow Left Ventricular Assist Device Support is Associated with Lower Rates of Cardiac Transplantation.
    Holley CT; Harvey L; Roy SS; Cogswell R; Eckman P; Liao K; John R
    ASAIO J; 2015; 61(6):635-9. PubMed ID: 26366686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An external validation study of the Utah Bleeding Risk Score.
    Peivandi A; Welp H; Scherer M; Sindermann JR; Wagner NM; Dell'Aquila AM
    Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35024851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of GI bleeding after implantation of left ventricular assist device.
    Kushnir VM; Sharma S; Ewald GA; Seccombe J; Novak E; Wang IW; Joseph SM; Gyawali CP
    Gastrointest Endosc; 2012 May; 75(5):973-9. PubMed ID: 22341716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carotid artery structure and hemodynamics and their association with adverse vascular events in left ventricular assist device patients.
    Kiyatkin ME; Zuver AM; Gaudig A; Javaid A; Mabasa M; Royzman E; McDonnell BJ; Yuzefpolskaya M; Colombo PC; Stöhr EJ; Willey JZ
    J Artif Organs; 2021 Jun; 24(2):182-190. PubMed ID: 33459911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel use of low-dose thalidomide in refractory gastrointestinal bleeding in left ventricular assist device patients.
    Seng BJJ; Teo LLY; Chan LL; Sim DKL; Kerk KL; Soon JL; Tan TE; Sivathasan C; Lim CP
    Int J Artif Organs; 2017 Oct; 40(11):636-640. PubMed ID: 28708213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II antagonists and gastrointestinal bleeding in left ventricular assist devices: A systematic review and meta-analysis.
    Kittipibul V; Vutthikraivit W; Kewcharoen J; Rattanawong P; Tantrachoti P; Putthapiban P; Nair N
    Int J Artif Organs; 2021 Mar; 44(3):215-220. PubMed ID: 32842844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.